The recent presentation of the long-term results of the JCOG0802 phase 3 trial has sparked discussion within the international thoracic surgical community. Initial 5-year results in 2022 reported a ...
Discover how Hyperbolic Absolute Risk Aversion models risk tolerance, influences investment choices, and simplifies financial ...